Gene content | ||||
---|---|---|---|---|
ANXA5 (-- by HUGO) | ||||
annexin A5 ---------- (Previous | ||||
-- | ||||
Annexin A5Thromboplastin InhibitorENX2Vascular Anticoagulant-AlphaANX5CBP-IAnchorin CIIPAP-IAnnexin VPP4Calphobindin IVAC-AlphaEndonexin IIRPRGL3Lipocortin VAnnexin-5Placental Anticoagulant Protein 4Annexin-5Placental Anticoagulant Protein | ||||
NCBI: 4q27 Ensembl: 4q27 | ||||
1ANW (3D) 1ANX (3D) 1AVH (3D) 1AVR (3D) 1HAK (3D) 1HVD (3D) |
Protein Domain/Family | ||||
---|---|---|---|---|
Source | ID | Domain | Name | Type |
InterPro | IPR001464 | Annexin | Annexin | Family |
IPR002392 | AnnexinV | Annexin, type V | Family | |
Blocks | IPB001464 | Annexin | Annexin | |
IPB002392 | Annexin type V signature | Annexin type V signature |
Disorder & Mutation | ||||
---|---|---|---|---|
Source | Disease | |||
SWISS-PROT | Defects in ANXA5 are associated with susceptibility to pregnancy loss, recurrent, type 3 (RPRGL3) [MIM:614391]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions |
ANXA5 cross reference | |||||||
---|---|---|---|---|---|---|---|
|